相关实验视频

Updated: Jan 15, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

临床医生反报告的非目标影响关于在医疗复杂的儿童中使用抗生素的报告,这些儿童因社区获得的肺炎住院治疗

Kathleen Chiotos^1,2,3,4, Lauren Dutcher⁵, Robert W Grundmeier^3,6

¹Division of Critical Care Medicine, Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, PA, United States.

Journal of the Pediatric Infectious Diseases Society

|October 6, 2025

概括

对抗生素使用的临床审计和反报告改善了医疗复杂的儿童的抗生素选择和持续时间,即使是那些未包括在原始报告中的儿童. 这表明这种反干预措施的影响更广泛.

科学领域:

儿科儿科儿科
传染性疾病传染性疾病
医疗保健服务研究医疗服务研究

背景情况:

之前的研究表明,临床医生审计和反报告改善了社区获得性肺炎的健康儿童的抗生素使用.
医疗复杂的儿童往往有不同的护理需求和与抗生素使用相关的结果.

研究的目的:

评估临床医生审计和反报告对医疗复杂儿童抗生素选择和持续时间的非目标影响.
要确定干预的好处是否超出了最初研究的人群.

主要方法:

使用了一个探索性研究设计.
收集了关于医疗复杂儿童抗生素选择和持续时间的数据.
这些儿童由接受审计和反报告的临床医生照顾.

主要成果:

反报告干预与医疗复杂的儿童对适当的抗生素选择和持续时间指标的坚持增加有关.
这种改善发生在医疗复杂的儿童被排除在原始报告之外.

结论:

临床医生反报告可能比特定的目标人群具有更广泛的影响.
这些发现表明,基于反的干预措施可能有利于更广泛的患者.
需要进一步的研究来评估这些更广泛的影响的安全性和有效性.

关键词:

抗微生物药物管理管理审计和反的审计和反.在社区获得的肺炎.复杂的慢性疾病 (CCC)医疗复杂的孩子

更多相关视频

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

相关概念视频

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Antibiotic Selection

Antibiotic Selection

Factors Affecting Drug Response: Overview

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...